NCT00449852View on ClinicalTrials.gov

Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Coronary Artery Disease
Interventions
BEHAVIORAL

Interactive Voice Response

The IVR group will receive a telephone call from the IVR system three, 14, 30, 90, 120 and 150 days after hospital discharge.

Trial Locations (1)

K1Y4W

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Ontario

OTHER

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT00449852 - Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease | Biotech Hunter | Biotech Hunter